Grant: Collaborative Health Research Projects
McMaster University
$47,000.00
Biomimetic intraocular lens surfaces for minimization of posterior capsule opacification
EF 2007-08
Résumé
Of the senses, vision is arguably the most important. Therefore, diseases of the eye leading to vision loss can have the most devastating impact on quality of life. The development of new and more effective ocular biomaterials can be expected to play a crucial role in the maintenance of vision health and a corresponding reduction in cost of care associated with supporting those with compromised vision. The current work focuses on the amelioration of posterior capsule opacification (PCO). Loss of transparency of the lens due to a cataract, the leading cause of blindness in the world, can be effectively treated by implantation of intraocular lenses. However, secondary cataract, or PCO, the major complication of modern cataract surgery with intraocular lens implantation, occurring in between 20 and 30% of cases is a common occurrence that requires further medical intervention. In PCO, lens epithelial cells remaining in the capsule after the surgery are triggered by unknown signals to proliferate and migrate over the surface of the IOL. Changes to the cell morphology result in the formation of distinct opacities, which disrupt vision. While the (accidental) evolution of intraocular lenses to include sharp edges has reduced the incidence of PCO requiring corrective surgery, perhaps by delaying its onset, the problem is far from being erradicated. In the current work, we use a logical approach to lens modification based on developing an understanding of the biological aspects of the process to regulate the signals received by the cells. Through the appropriate modification of the materials to better mimic the native biology, it is believed that new intraocular lens materials with improved properties can be developed.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
323252-2006
Name nom
Sheardown, Heather
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
47000
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
2
Nb partie
3
Application title
Biomimetic intraocular lens surfaces for minimization of posterior capsule opacification
Keyword
NA
Application summary
Of the senses, vision is arguably the most important. Therefore, diseases of the eye leading to vision loss can have the most devastating impact on quality of life. The development of new and more effective ocular biomaterials can be expected to play a crucial role in the maintenance of vision health and a corresponding reduction in cost of care associated with supporting those with compromised vision. The current work focuses on the amelioration of posterior capsule opacification (PCO). Loss of transparency of the lens due to a cataract, the leading cause of blindness in the world, can be effectively treated by implantation of intraocular lenses. However, secondary cataract, or PCO, the major complication of modern cataract surgery with intraocular lens implantation, occurring in between 20 and 30% of cases is a common occurrence that requires further medical intervention. In PCO, lens epithelial cells remaining in the capsule after the surgery are triggered by unknown signals to proliferate and migrate over the surface of the IOL. Changes to the cell morphology result in the formation of distinct opacities, which disrupt vision. While the (accidental) evolution of intraocular lenses to include sharp edges has reduced the incidence of PCO requiring corrective surgery, perhaps by delaying its onset, the problem is far from being erradicated. In the current work, we use a logical approach to lens modification based on developing an understanding of the biological aspects of the process to regulate the signals received by the cells. Through the appropriate modification of the materials to better mimic the native biology, it is believed that new intraocular lens materials with improved properties can be developed.